
Pharma Pulse 5/27/24: New Study on Physician Compensation, Overwork, and Shortage, Evolving Clinical Research & more
The latest news for pharma industry insiders.
ICON plc CEO Steve Cutler discussed how strategic partnerships are driving advancements in clinical trials.
The FDA-approved AI algorithm called ProFound AI was more likely to show a false-positive cancer diagnosis in the mammograms of Black women, when compared to White, Hispanic or Asian women, new research shows.
For two weeks at the 140-hospital system, doctors and nurses have had little access to digital records for patient histories, resorting to paper and faxes to treat people.
Doximity, Inc. has released its 2024 Physician Compensation Report. The report reveals that the average pay for doctors increased 5.9% in 2023 after a decline of 2.4% the previous year. The report also points to a 23% gender wage gap, with men physicians earning nearly $102,000 more than women physicians, even when controlling for specialty, location, and years of experience.
Fostering collaboration between Medical Affairs and Commercial teams is an emerging strategy for pharmaceutical companies to harness their unique insights and expertise. Dive into the comprehensive discussion by John Kane and Todd Parker, PhD, CMPP featured in Pharmaceutical Executive:https://bit.ly/4bzkXu2.
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

